JPH01500265A - キシロメタゾリン含有薬物学的製剤 - Google Patents

キシロメタゾリン含有薬物学的製剤

Info

Publication number
JPH01500265A
JPH01500265A JP62503730A JP50373087A JPH01500265A JP H01500265 A JPH01500265 A JP H01500265A JP 62503730 A JP62503730 A JP 62503730A JP 50373087 A JP50373087 A JP 50373087A JP H01500265 A JPH01500265 A JP H01500265A
Authority
JP
Japan
Prior art keywords
xylometazoline
oil
pharmaceutical preparations
preparations containing
triglyceride
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP62503730A
Other languages
English (en)
Japanese (ja)
Inventor
レーベル,クラウス‐デイーター
Original Assignee
アシエ アクチエンゲゼルシヤフト
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by アシエ アクチエンゲゼルシヤフト filed Critical アシエ アクチエンゲゼルシヤフト
Publication of JPH01500265A publication Critical patent/JPH01500265A/ja
Pending legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4151,2-Diazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/61Myrtaceae (Myrtle family), e.g. teatree or eucalyptus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/26Psychostimulants, e.g. nicotine, cocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/16Otologicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
JP62503730A 1986-07-18 1987-06-24 キシロメタゾリン含有薬物学的製剤 Pending JPH01500265A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19863624624 DE3624624A1 (de) 1986-07-18 1986-07-18 Xylometazolinhaltige pharmazeutische praeparate
DE3624624.7 1986-07-18

Publications (1)

Publication Number Publication Date
JPH01500265A true JPH01500265A (ja) 1989-02-02

Family

ID=6305642

Family Applications (1)

Application Number Title Priority Date Filing Date
JP62503730A Pending JPH01500265A (ja) 1986-07-18 1987-06-24 キシロメタゾリン含有薬物学的製剤

Country Status (12)

Country Link
EP (1) EP0282495B1 (da)
JP (1) JPH01500265A (da)
AU (1) AU7547387A (da)
DE (2) DE3624624A1 (da)
DK (1) DK149588A (da)
ES (1) ES2004454A6 (da)
FI (1) FI881271A7 (da)
GR (1) GR871134B (da)
IL (1) IL83177A0 (da)
PT (1) PT85350B (da)
WO (1) WO1988000473A1 (da)
ZA (1) ZA875281B (da)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL1011016C2 (nl) * 1999-01-13 2000-07-14 Dagra Pharma Bv Neusspray op basis van xylometazoline en kamille-extract.

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3339236A1 (de) * 1983-10-28 1985-05-09 Bayer Ag Arzneimittelzubereitung

Also Published As

Publication number Publication date
IL83177A0 (en) 1987-12-31
FI881271L (fi) 1988-03-17
ZA875281B (en) 1988-03-30
FI881271A0 (fi) 1988-03-17
DK149588D0 (da) 1988-03-18
ES2004454A6 (es) 1989-01-01
WO1988000473A1 (fr) 1988-01-28
FI881271A7 (fi) 1988-03-17
PT85350A (de) 1987-08-01
AU7547387A (en) 1988-02-10
EP0282495A1 (de) 1988-09-21
DE3770939D1 (de) 1991-07-25
DK149588A (da) 1988-03-18
GR871134B (en) 1987-11-20
DE3624624A1 (de) 1988-01-28
PT85350B (de) 1989-10-16
EP0282495B1 (de) 1991-06-19

Similar Documents

Publication Publication Date Title
Allen et al. Selenium sulfide: adjunctive therapy for tinea capitis
EA199900991A1 (ru) Медицинские аэрозольные препараты
EP0221041A3 (en) Benzimidazole derivatives, process for their preparation and their pharmaceutical use
DE69223914D1 (de) 4-substituierte-2-Deoxy-2,3-Didehydro Alpha-D-Neuraminsäure antivirale Derivate
TNSN91085A1 (fr) Composition pharmaceutique sous forme de gel dans un emballage distributeur
ES2073164T3 (es) Liposomas heterovesiculares.
IL80149A (en) Pharmaceutical compositions containing toluidide derivatives against graft-versus-host diseases and autoimmune diseases
PT723437E (pt) Preparacao farmaceutica por unidades multiplas contendo um inibidor da bomba de protoes
MX9204627A (es) Compuestos 1-acilpiperidina, procedimiento para su preparacion y composicion farmaceutica que los comprende.
DE69111582D1 (de) 1,4-Disubstituierte Piperazine, Verfahren zu deren Herstellung und diese enthaltende pharmazeutische Zusammenstellungen.
JPS5513275A (en) Prodrug of non-steroid anti-inflammatory drug having improved absorption and anti-inflammatory drug composition comprising it
ATE283047T1 (de) Verwendung von ibudilast zur herstellung eines arzneimittels zur behandlung multiple sklerose
FI86690B (fi) Foerfarande foer framstaellning av oxazafosforinloesningar.
JPH01500265A (ja) キシロメタゾリン含有薬物学的製剤
DE3764111D1 (de) Arzneimittelkombination.
SE8600658D0 (sv) Novel composition of matter
DK429480A (da) Phosphonohydroxyeddikesyre fremgangsmaader til fremstilling deraf samt anvendelse deraf som laegemiddel
ATE13488T1 (de) Gallium-chlorid, ein neues antikrebsmittel.
DE69804169D1 (de) Oral anzuwendende flüssige Arzneilösung
HUP0001773A2 (hu) Szubsztituált tetrahidropiridinszármazékok, eljárás előállításukra, továbbá a vegyületeket tartalmazó gyógyászati készítmények
ATE40793T1 (de) Pharmazeutisches praeparat zur therapeutischen behandlung von rheumatischen erkrankungen.
RU95101900A (ru) Лекарственный препарат для лечения артрита и способ его приготовления
FR2432316A1 (fr) Nouveaux medicaments contenant, a titre de substance active, des composes de type benzenesulfone, nouveaux composes de ce type et procede pour leur preparation
AT342761B (de) Verfahren zur herstellung von homopyrimidazol-derivate enthaltenden, stabilen pharmazeutischen praparaten zur oralen verabreichung
ATE53024T1 (de) Biologisch aktive substanz, girolline genannt, extrahiert aus dem schwamm pseudaxinyssa cantharella, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzungen.